News & Updates

Felcisetrag shows therapeutic potential in gastric, intestinal motility disorders

19 Mar 2021

Treatment with the highly selective 5‐HT4 receptor agonist felcisetrag appears to significantly speed up gastric, small bowel, and colonic transit in patients with gastroparesis, as shown in a study.

Felcisetrag shows therapeutic potential in gastric, intestinal motility disorders

19 Mar 2021

H. pylori treatment slows progression in pre-gastric cancer

18 Mar 2021

Anti-Helicobacter pylori treatment provides long-term protection against histological progression among patients at high risk of developing gastric cancer, a new study has found.

H. pylori treatment slows progression in pre-gastric cancer

18 Mar 2021

Vaginal delivery linked to sapovirus-related acute gastroenteritis in early childhood

16 Mar 2021

Sapovirus is a common aetiology of acute gastroenteritis (AGE), suggests a study in a Central American setting. Symptoms are akin to AGE associated with other aetiologies.

Vaginal delivery linked to sapovirus-related acute gastroenteritis in early childhood

16 Mar 2021

Adding bemarituzumab to chemo may up survival in advanced FGFR2b+, HER2- gastric cancer

11 Mar 2021 by

Adding bemarituzumab to mFOLFOX6 significantly improved survival outcomes and response rate compared with mFOLFOX6 alone in patients FGFR2b-positive, HER2-negative gastric cancer, according to the FIGHT study presented at the 2021 ASCO GI Cancer Symposium.

Adding bemarituzumab to chemo may up survival in advanced FGFR2b+, HER2- gastric cancer

11 Mar 2021

GI cancer patients could continue therapy during COVID-19 pandemic

10 Mar 2021 by

Results of a single-centre study in the UK have suggested that patients receiving systemic anticancer therapy for gastrointestinal (GI) cancers could continue their treatment during the COVID-19 pandemic.

GI cancer patients could continue therapy during COVID-19 pandemic

10 Mar 2021

Constipation may be warning sign of falling in early PD

10 Mar 2021

In patients with early Parkinson’s disease (PD), risk factors for falling are often associated with gastrointestinal dysautonomia, a recent Korea study has found.

Constipation may be warning sign of falling in early PD

10 Mar 2021

First-line infliximab shows promise in children with moderate-to-severe CD

09 Mar 2021

Use of infliximab in the first line setting appears to yield better results than conventional treatment in children with moderate-to-severe Crohn’s disease (CD), facilitating short-term clinical and endoscopic remission and being associated with a greater likelihood of maintaining clinical remission at week 52 on azathioprine monotherapy, according to a study.

First-line infliximab shows promise in children with moderate-to-severe CD

09 Mar 2021

ATTRACTION-3: Nivolumab significantly improves OS in advanced ESCC

08 Mar 2021 by

Treatment with nivolumab led to significantly improved overall survival (OS) in patients with advanced oesophageal squamous cell carcinoma (ESCC), according to updated results of the ATTRACTION-3* study presented at ASCO GI 2021.

ATTRACTION-3: Nivolumab significantly improves OS in advanced ESCC

08 Mar 2021

Methylprednisolone + standard care may reduce HBV-ACLF–related mortality

05 Mar 2021 by

The addition of methylprednisolone to standard care* reduced mortality risk in patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF), according to a study from China.

Methylprednisolone + standard care may reduce HBV-ACLF–related mortality

05 Mar 2021

Patients with achalasia at risk of oesophageal cancer

04 Mar 2021

Achalasia is associated with an increased risk of developing both squamous cell carcinoma and adenocarcinoma of the oesophagus, reveals a study, noting, however, that the annual incidence of oesophageal cancer is rather low.

Patients with achalasia at risk of oesophageal cancer

04 Mar 2021

News & Updates

Filter by Specialty:

Specialty:

Felcisetrag shows therapeutic potential in gastric, intestinal motility disorders

Felcisetrag shows therapeutic potential in gastric, intestinal motility disorders

H. pylori treatment slows progression in pre-gastric cancer

H. pylori treatment slows progression in pre-gastric cancer

Vaginal delivery linked to sapovirus-related acute gastroenteritis in early childhood

Vaginal delivery linked to sapovirus-related acute gastroenteritis in early childhood

Adding bemarituzumab to chemo may up survival in advanced FGFR2b+, HER2- gastric cancer

Adding bemarituzumab to chemo may up survival in advanced FGFR2b+, HER2- gastric cancer

GI cancer patients could continue therapy during COVID-19 pandemic

GI cancer patients could continue therapy during COVID-19 pandemic

Constipation may be warning sign of falling in early PD

Constipation may be warning sign of falling in early PD

First-line infliximab shows promise in children with moderate-to-severe CD

First-line infliximab shows promise in children with moderate-to-severe CD

ATTRACTION-3: Nivolumab significantly improves OS in advanced ESCC

ATTRACTION-3: Nivolumab significantly improves OS in advanced ESCC

Methylprednisolone + standard care may reduce HBV-ACLF–related mortality

Methylprednisolone + standard care may reduce HBV-ACLF–related mortality

Patients with achalasia at risk of oesophageal cancer

Patients with achalasia at risk of oesophageal cancer